These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11325893)

  • 21. Homocysteine and progression of coronary artery disease.
    Skibińska E; Sawicki R; Lewczuk A; Prokop J; Musiał W; Kowalska I; Mroczko B
    Kardiol Pol; 2004 Mar; 60(3):197-205. PubMed ID: 15156215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma homocysteine predicts progression of atherosclerosis.
    Rasouli ML; Nasir K; Blumenthal RS; Park R; Aziz DC; Budoff MJ
    Atherosclerosis; 2005 Jul; 181(1):159-65. PubMed ID: 15939068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperhomocysteinemia is an independent risk factor in young patients with coronary artery disease in southern China.
    Wu Y; Huang Y; Hu Y; Zhong J; He Z; Li W; Yang Y; Xu D; Wu S
    Herz; 2013 Nov; 38(7):779-84. PubMed ID: 23430091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma homocysteine levels and late outcome in patients with unstable angina.
    Vizzardi E; Nodari S; Fiorina C; Metra M; Dei Cas L
    Cardiology; 2007; 107(4):354-9. PubMed ID: 17283425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperhomocysteinemia as a cardiovascular risk factor in Indian women: determinants and directionality.
    Pandey SN; Vaidya AD; Vaidya RA; Talwalkar S
    J Assoc Physicians India; 2006 Oct; 54():769-74. PubMed ID: 17214272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation.
    Jonasson T; Ohlin AK; Gottsäter A; Hultberg B; Ohlin H
    Clin Chem Lab Med; 2005; 43(6):628-34. PubMed ID: 16006259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of vitamin-optimized plasma homocysteine cutoff values on the prevalence of hyperhomocysteinemia in healthy adults.
    Fokkema MR; Weijer JM; Dijck-Brouwer DA; van Doormaal JJ; Muskiet FA
    Clin Chem; 2001 Jun; 47(6):1001-7. PubMed ID: 11375284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population.
    Wang XL; Duarte N; Cai H; Adachi T; Sim AS; Cranney G; Wilcken DE
    Atherosclerosis; 1999 Sep; 146(1):133-40. PubMed ID: 10487496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events.
    Krempl TK; Maas R; Sydow K; Meinertz T; Böger RH; Kähler J
    Eur Heart J; 2005 Sep; 26(18):1846-51. PubMed ID: 15860520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of oxidative stress with elevated level of DNA damage and homocysteine in cardiovascular disease patients.
    Qasim M; Bukhari SA; Ghani MJ; Masoud MS; Huma T; Arshad M; Haque A; Ibrahim Z; Javed S; Rajoka MI
    Pak J Pharm Sci; 2016 Nov; 29(6 Suppl):2297-2302. PubMed ID: 28167469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute and convalescent changes in plasma homocysteine concentrations in acute coronary syndromes.
    Al-Obaidi MK; Stubbs PJ; Amersey R; Noble MI
    Heart; 2001 Apr; 85(4):380-4. PubMed ID: 11250957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of oxidative stress biomarkers in hypertensive patients with or without hyperhomocysteinemia.
    Guo G; Sun W; Liu G; Zheng H; Zhao J
    Clin Exp Hypertens; 2018; 40(3):262-266. PubMed ID: 28920709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical relevance of plasma homocysteine levels in Taiwanese patients with coronary artery disease.
    Cheng ML; Ho HY; Lin JF; Chen YC; Chan EC; Chiu DT
    Biofactors; 2008; 34(2):125-34. PubMed ID: 19706978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homocysteine diminishes apolipoprotein A-I function and expression in patients with hypothyroidism: a cross-sectional study.
    Yang N; Yao Z; Miao L; Liu J; Gao X; Xu Y; Wang G
    Lipids Health Dis; 2016 Jul; 15():123. PubMed ID: 27457726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intense lipid peroxidation in premature clinical coronary atherosclerosis is associated with metabolic abnormalities.
    Fabbi P; Ghigliotti G; Brunelli C; Balbi M; Spallarossa P; Rossettin P; Barsotti A; Odetti P; Garibaldi S
    J Lab Clin Med; 2004 Feb; 143(2):99-105. PubMed ID: 14966465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nontraditional atherosclerotic risk factors and extent of coronary atherosclerosis in patients with combined impaired fasting glucose and impaired glucose tolerance.
    Surdacki A; Stochmal E; Szurkowska M; Bode-Böger SM; Martens-Lobenhoffer J; Stochmal A; Klecha A; Kawecka-Jaszcz K; Dubiel JS; Huszno B; Szybiński Z
    Metabolism; 2007 Jan; 56(1):77-86. PubMed ID: 17161229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 13N-ammonia rest/stress PET: folic acid improves global coronary vasoreactivity in coronary artery disease patients with normal or elevated homocysteine levels.
    Graf S; Nikfardjam M; Khorsand A; Ofluoglu S; Nekolla S; Dudczak R; Maurer G; Kletter K; Huber K; Pirich C
    Nuklearmedizin; 2006; 45(6):248-53. PubMed ID: 17149493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical usefulness of a HPLC method for simultaneous quantitation of plasma homocysteine and cysteine.
    Atamasirikul K; Kajanachumpol S; Wilairat P; Tantibhedhyangkul P
    J Med Assoc Thai; 2008 Mar; 91(3):338-44. PubMed ID: 18575286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No evidence for oxidative stress as a mechanism of action of hyperhomocysteinemia in humans.
    Huerta JM; González S; Fernández S; Patterson AM; Lasheras C
    Free Radic Res; 2004 Nov; 38(11):1215-21. PubMed ID: 15621699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.